Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of CDP870 in Patients With Early-stage Rheumatoid Arthritis Who Are Naïve to Methotrexate and Have Poor Prognostic Factors
certolizumab pegol
CDP870-275-11-001
NCT01451203
Rheumatoid Arthritis
Phase 3
 
June 2017

Powered by ideaPoint, Inc.